Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 19/20 | 0.86 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.86 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.86 |
| ▸ | MEN1 | O00255 | 1/20 | 0.86 |
| ▸ | PDE2A | O00408 | 1/20 | 0.86 |
| ▸ | RGS12 | O14924 | 1/20 | 0.86 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.86 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.86 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.86 |
| ▸ | ABCC5 | O15440 | 1/20 | 0.86 |
| ▸ | PDE6D | O43924 | 1/20 | 0.86 |
| ▸ | PDE8A | O60658 | 1/20 | 0.86 |
| ▸ | GMNN | O75496 | 1/20 | 0.86 |
| ▸ | USP2 | O75604 | 1/20 | 0.86 |
| ▸ | PDE5A | O76074 | 1/20 | 0.86 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.86 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.86 |
| ▸ | LMNA | P02545 | 1/20 | 0.86 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.86 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dipyridamole SCHEMBL16119 | 0.93 | SLC29A1 (1.00) | SLC29A1ADORA3KDM4EMEN1PDE2A | |
| Dipyridamole SCHEMBL3980595 | 0.93 | SLC29A1 (1.00) | SLC29A1ADORA3KDM4EMEN1PDE2A | |
| SCHEMBL17896290 | 0.92 | SLC29A1 (0.72) | SLC29A1ADORA3KDM4EMEN1PDE2A | |
| Dipyridamole SCHEMBL9743915 | 0.91 | SLC29A1 (0.97) | SLC29A1ADORA3KDM4EMEN1PDE2A | |
| Dipyridamole SCHEMBL7362290 | 0.91 | SLC29A1 (0.97) | SLC29A1ADORA3KDM4EMEN1PDE2A | |
| Dipyridamole SCHEMBL7998210 | 0.91 | SLC29A1 (0.97) | SLC29A1ADORA3KDM4EMEN1PDE2A | |
| Dipyridamole SCHEMBL17044166 | 0.90 | SLC29A1 (0.94) | SLC29A1ADORA3KDM4EMEN1PDE2A | |
| Dipyridamole SCHEMBL611283 | 0.88 | SLC29A1 (0.91) | SLC29A1ADORA3KDM4EMEN1PDE2A | |
| Dipyridamole SCHEMBL11234613 | 0.86 | SLC29A1 (0.86) | SLC29A1ADORA3KDM4EMEN1PDE2A | |
| SCHEMBL17017272 | 0.86 | SLC29A1 (0.86) | SLC29A1ADORA3KDM4EMEN1PDE2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025013872-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | 出光興産株式会社 | 2025-01-16 | — | — | WO | claimed |
| CN-118291517-A | Genetic transformation method for young embryo of induction system by using agrobacterium infection | 中国农业大学 | 2024-07-05 | — | — | CN | claimed |
| CN-114740102-A | Dipyridamole impurity positioning solution and preparation method and application thereof | 广东省药品检验所（广东省药品质量研究所、广东省口岸药品检验所） | 2022-07-12 | — | — | CN | claimed |
| CN-112581743-B | Infrared remote control cascade circuit | 广州朗国电子科技股份有限公司 | 2022-03-08 | — | — | CN | claimed |
| US-12540144-B2 | Rapafucin derivative compounds and methods of use thereof | THE JOHNS HOPKINS UNIVERSITY (US) | 2026-02-03 | — | — | US | disclosed |
| WO-2025013872-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | 出光興産株式会社 | 2025-01-16 | — | — | WO | disclosed |
| CN-114740102-B | Dipyridamole Mo Zazhi positioning solution and preparation method and application thereof | 广东省药品检验所（广东省药品质量研究所、广东省口岸药品检验所） | 2024-12-24 | — | — | CN | disclosed |
| US-20240239810-A1 | RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOF | THE JOHNS HOPKINS UNIVERSITY | 2024-07-18 | — | — | US | disclosed |
| CN-118291517-A | Genetic transformation method for young embryo of induction system by using agrobacterium infection | 中国农业大学 | 2024-07-05 | — | — | CN | disclosed |
| US-11945827-B2 | Rapafucin derivative compounds and methods of use thereof | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-04-02 | — | — | US | disclosed |
| US-20230000996-A1 | RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOF | THE JOHNS HOPKINS UNIVERSITY | 2023-01-05 | — | — | US | disclosed |
| US-20220363692-A1 | RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOF | THE JOHNS HOPKINS UNIVERSITY | 2022-11-17 | — | — | US | disclosed |
| CN-114740102-A | Dipyridamole impurity positioning solution and preparation method and application thereof | 广东省药品检验所（广东省药品质量研究所、广东省口岸药品检验所） | 2022-07-12 | — | — | CN | disclosed |
| CN-114740102-A | Dipyridamole impurity positioning solution and preparation method and application thereof | 广东省药品检验所（广东省药品质量研究所、广东省口岸药品检验所） | 2022-07-12 | — | — | CN | disclosed |
| CN-112581743-B | Infrared remote control cascade circuit | 广州朗国电子科技股份有限公司 | 2022-03-08 | — | — | CN | disclosed |
| US-9381197-B2 | Processes for the preparation of dipyridamole | GENERICS [UK] LIMITED (GB) | 2016-07-05 | — | — | US | disclosed |
| US-9381197-B2 | Processes for the preparation of dipyridamole | GENERICS [UK] LIMITED (GB) | 2016-07-05 | — | — | US | disclosed |
| EP-1894561-A1 | Dipyridamole pharmaceutical compositions | Dr. Reddy's Laboratories Ltd. (IN) | 2008-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220363692-A1 | RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOF | RICTOR, FKBP14, MTOR | SLC29A1 3759/4885ADORA3 4468/4885KDM4E 3663/4885 |
| US-20230000996-A1 | RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOF | RICTOR, FKBP14, MTOR | SLC29A1 3759/4885ADORA3 4468/4885KDM4E 3663/4885 |
| US-11945827-B2 | Rapafucin derivative compounds and methods of use thereof | RICTOR, FKBP14, MTOR | SLC29A1 3759/4885ADORA3 4468/4885KDM4E 3663/4885 |
| US-12540144-B2 | Rapafucin derivative compounds and methods of use thereof | RICTOR, CHP1, FKBP8 | SLC29A1 1736/4885ADORA3 4421/4885KDM4E 4000/4885 |
| US-20240239810-A1 | RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOF | RICTOR, MTOR, FKBP14 | SLC29A1 3334/4885ADORA3 4498/4885KDM4E 3832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.